Robert Baffi - Jan 16, 2024 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role
Director
Signature
/s/ Christine Mikail, as attorney-in-fact for Robert Baffi
Stock symbol
NGNE
Transactions as of
Jan 16, 2024
Transactions value $
$0
Form type
4
Date filed
1/18/2024, 06:51 PM
Previous filing
Dec 26, 2023
Next filing
Jun 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGNE Stock Option (Right to Buy) Award $0 +15.4K $0.00 15.4K Jan 16, 2024 Common Stock 15.4K $32.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents the right to purchase 15,400 shares of common stock of the Issuer, and vests in equal monthly installments through January 16, 2027, subject to the reporting person's continued service to the Issuer through each applicable vesting date.